OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association between sodium-glucose cotransporter-2 inhibitors and incident atrial fibrillation/atrial flutter in heart failure patients with reduced ejection fraction: a meta-analysis of randomized controlled trials
Dimitrios Sfairopoulos, Tong Liu, Nan Zhang, et al.
Heart Failure Reviews (2022) Vol. 28, Iss. 4, pp. 925-936
Open Access | Times Cited: 15
Dimitrios Sfairopoulos, Tong Liu, Nan Zhang, et al.
Heart Failure Reviews (2022) Vol. 28, Iss. 4, pp. 925-936
Open Access | Times Cited: 15
Showing 15 citing articles:
SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study
Jiang Li, Yuefeng Yu, Ying Sun, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Jiang Li, Yuefeng Yu, Ying Sun, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 25
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
Aritra Paul, Chadi Tabaja, Oussama M. Wazni
International Journal of Arrhythmia (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Aritra Paul, Chadi Tabaja, Oussama M. Wazni
International Journal of Arrhythmia (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives
Alfredo Mauriello, Antonia Ascrizzi, Anna Selvaggia Roma, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 806-806
Open Access | Times Cited: 5
Alfredo Mauriello, Antonia Ascrizzi, Anna Selvaggia Roma, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 806-806
Open Access | Times Cited: 5
The Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence and Long‐Term Clinical Outcomes in HFrEF Patients Undergoing Cryoballoon Ablation: A New Frontier Beyond Diabetes and Heart Failure
Elif Hande Özcan Çetin, Mehmet Serkan Çetin, Hasan Can Könte, et al.
Journal of Cardiovascular Electrophysiology (2025)
Closed Access
Elif Hande Özcan Çetin, Mehmet Serkan Çetin, Hasan Can Könte, et al.
Journal of Cardiovascular Electrophysiology (2025)
Closed Access
The Off-Target Cardioprotective Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors: An Overview
Loredana N. Ionică, Adina V. Lința, Alina D. Bătrîn, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7711-7711
Open Access | Times Cited: 2
Loredana N. Ionică, Adina V. Lința, Alina D. Bătrîn, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7711-7711
Open Access | Times Cited: 2
Characterizing atrial fibrillation in patients with and without heart failure across the ejection fraction spectrum: Incidence, prevalence, and treatment strategies
Valeria Valente, Giulia Ferrannini, Lina Benson, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 2
Valeria Valente, Giulia Ferrannini, Lina Benson, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 2
Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review
Xiaolan Ouyang, Jiafu Wang, Qian Chen, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Xiaolan Ouyang, Jiafu Wang, Qian Chen, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Sodium–Glucose Transporter 2 Inhibitors in Heart Failure: An Overview of Systematic Reviews
Yixuan Fang, Lihong Chen, Shiyi Sun, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 7, pp. 198-198
Open Access | Times Cited: 1
Yixuan Fang, Lihong Chen, Shiyi Sun, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 7, pp. 198-198
Open Access | Times Cited: 1
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study
Xinyi Gao, Nan Zhang, Lei Lü, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 2, pp. 103-117
Open Access | Times Cited: 4
Xinyi Gao, Nan Zhang, Lei Lü, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 2, pp. 103-117
Open Access | Times Cited: 4
Effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) on the clinical outcomes of patients with diabetic atrial fibrillation
Selim Aydemir, Sidar Şiyar Aydın, Emrah Aksakal, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Selim Aydemir, Sidar Şiyar Aydın, Emrah Aksakal, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Emerging sodium-glucose cotransporter-2 inhibitor therapies for managing heart failure in patients with chronic kidney disease
Jeffrey Shi Kai Chan, Francesco Perone, Yasmin Bayatpoor, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 8, pp. 935-945
Closed Access | Times Cited: 3
Jeffrey Shi Kai Chan, Francesco Perone, Yasmin Bayatpoor, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 8, pp. 935-945
Closed Access | Times Cited: 3
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: A Chinese population-based cohort study
Xinyi Gao, Nan Zhang, Lei Lü, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Xinyi Gao, Nan Zhang, Lei Lü, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Rationale and design of a randomized trial of the dapagliflozin evaluation on atrial fibrillation patients followed Cox-Maze IV: the DETAIL-CMIV study
Zhan Peng, Florian Osmanaj, Yunxiao Yang, et al.
EP Europace (2023) Vol. 25, Iss. 11
Open Access | Times Cited: 2
Zhan Peng, Florian Osmanaj, Yunxiao Yang, et al.
EP Europace (2023) Vol. 25, Iss. 11
Open Access | Times Cited: 2
Impact of SGLT2 inhibitors on cardiovascular outcomes and metabolic events in Chinese han patients with chronic heart failure
Fei Li, Rewaan Baheti, Mengying Jin, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access
Fei Li, Rewaan Baheti, Mengying Jin, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access
Meta-analysis addressing the impact of sodium-glucose Co-transporter-2 inhibitors on the risk for atrial fibrillation among individuals with heart failure with preserved ejection fraction
Dimitrios Patoulias, Theodoros Michailidis, Athina Dimosiari, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2022) Vol. 15, pp. 200161-200161
Open Access | Times Cited: 2
Dimitrios Patoulias, Theodoros Michailidis, Athina Dimosiari, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2022) Vol. 15, pp. 200161-200161
Open Access | Times Cited: 2
